These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32242868)

  • 1. Generalized hypertrichosis in an infant after treatment with propranolol for infantile hemangioma.
    Mendez-Gallart R; García-Palacios M; Cortizo-Vazquez J; Bautista-Casasnovas A
    Indian J Dermatol Venereol Leprol; 2020; 86(3):311-313. PubMed ID: 32242868
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral propranolol for infantile haemangioma may be associated with transient gross motor delay.
    Mahon C; Heron G; Perkins D; Drage A; Wargon O
    Br J Dermatol; 2018 Jun; 178(6):1443-1444. PubMed ID: 29330846
    [No Abstract]   [Full Text] [Related]  

  • 3. Individualized dosing of oral propranolol for treatment of infantile hemangioma: a prospective study.
    Prasad A; Sinha AK; Kumar B; Prasad A; Kumari M
    Pan Afr Med J; 2019; 32():155. PubMed ID: 31303926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sleep disturbances as an adverse effect of propranolol use in children with infantile hemangioma.
    Xerfan EMS; Andersen ML; Facina AS; Tufik S; Tomimori J
    World J Pediatr; 2020 Oct; 16(5):537-538. PubMed ID: 32016783
    [No Abstract]   [Full Text] [Related]  

  • 5. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
    Farshchian M; Potts GA
    Australas J Dermatol; 2021 Nov; 62(4):e580-e581. PubMed ID: 34293182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In brief: oral propranolol infantile hemangiomas.
    Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
    [No Abstract]   [Full Text] [Related]  

  • 7. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How "unsafe" is propranolol when used in the treatment of infantile hemangioma?
    Prashanth GP
    J Am Acad Dermatol; 2012 May; 66(5):854-5; author reply 855-6. PubMed ID: 22507576
    [No Abstract]   [Full Text] [Related]  

  • 9. Propranolol induced hypoglycemia.
    Horev A; Haim A; Zvulunov A
    Pediatr Endocrinol Rev; 2015 Mar; 12(3):308-10. PubMed ID: 25962208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of neurodevelopmental abnormalities in children treated with propranolol.
    Labrèze C; Voisard JJ; Delarue A; Moore N
    Br J Dermatol; 2015 Dec; 173(6):1562-4. PubMed ID: 26135132
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemangioma can be effectively treated with propranolol. Experiences from twelve cases, with promising results and few side effects].
    Rosenkvist CJ; Brudin L; Jörgensen E
    Lakartidningen; 2013 May 7-21; 110(19-20):942-5. PubMed ID: 23745499
    [No Abstract]   [Full Text] [Related]  

  • 12. Deep coma in a child treated with propranolol for infantile hemangioma.
    Bakalli I; Kola E; Lluka R; Celaj E; Sala D; Gjeta I; Sallabanda S; Klironomi D
    BMC Pediatr; 2019 Jul; 19(1):216. PubMed ID: 31266444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propranolol for infantile haemangiomas and neuroglycopenic seizures.
    Fusilli G; Merico G; Gurrado R; Rosa T; Acquafredda A; Cavallo L
    Acta Paediatr; 2010 Dec; 99(12):1756. PubMed ID: 20726852
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of oral propranolol in the treatment of infantile subglottic hemangioma.
    Li XY; Wang Y; Jin L; Chen JR
    Int J Clin Pharmacol Ther; 2016 Sep; 54(9):675-81. PubMed ID: 27285465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report.
    Breur JM; de Graaf M; Breugem CC; Pasmans SG
    Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [News on infantile hemangioma therapy by beta-blocker].
    Delmotte N; Curti C; Montana M; Crozet M; Vanelle P; Gensollen S
    Therapie; 2012; 67(3):257-65. PubMed ID: 22874493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas.
    Lund EB; Chamlin SL; Mancini AJ
    Pediatr Dermatol; 2018 Jul; 35(4):e233-e234. PubMed ID: 29683225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse Drug Reactions Following Propranolol in Infantile Hemangioma.
    Pandey V; Tiwari P; Imran M; Mishra A; Kumar D; Sharma SP
    Indian Pediatr; 2021 Aug; 58(8):753-755. PubMed ID: 34465658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of propranolol therapy in Moroccan children with infantile hemangioma.
    Lahrichi A; Hali F; Baline K; Fatoiki FZE; Chiheb S; Khadir K
    Arch Pediatr; 2018 Nov; 25(8):449-451. PubMed ID: 30361087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.